BlackRock Finance, Inc. - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 256 filers reported holding 10X GENOMICS INC in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q2 2024$124,337,031
-44.9%
6,392,650
+6.4%
0.00%
-40.0%
Q1 2024$225,466,842
-29.4%
6,007,643
+5.3%
0.01%
-37.5%
Q4 2023$319,273,759
+41.1%
5,705,392
+4.0%
0.01%
+14.3%
Q3 2023$226,309,632
-25.0%
5,486,294
+1.5%
0.01%
-12.5%
Q2 2023$301,701,063
+3.2%
5,402,956
+3.1%
0.01%
-11.1%
Q1 2023$292,289,781
+50.8%
5,239,107
-1.5%
0.01%
+50.0%
Q4 2022$193,847,099
+33.7%
5,319,624
+4.5%
0.01%
+20.0%
Q3 2022$145,036,000
-53.0%
5,092,563
-25.4%
0.01%
-50.0%
Q2 2022$308,706,000
-55.7%
6,822,248
-25.5%
0.01%
-47.4%
Q1 2022$696,572,000
-41.7%
9,156,992
+14.2%
0.02%
-36.7%
Q4 2021$1,194,454,000
-1.8%
8,018,634
-4.0%
0.03%
-11.8%
Q3 2021$1,216,273,000
-17.7%
8,354,676
+10.7%
0.03%
-17.1%
Q2 2021$1,478,280,000
+53.9%
7,549,175
+42.2%
0.04%
+46.4%
Q1 2021$960,591,000
+31.4%
5,307,139
+2.8%
0.03%
+21.7%
Q4 2020$731,084,000
+78.3%
5,163,020
+57.0%
0.02%
+53.3%
Q3 2020$410,012,000
+169.5%
3,288,510
+93.0%
0.02%
+150.0%
Q2 2020$152,162,000
+424.9%
1,703,738
+266.3%
0.01%
+500.0%
Q1 2020$28,989,000
-18.2%
465,129
+0.0%
0.00%0.0%
Q4 2019$35,458,000
-23.0%
465,022
-49.1%
0.00%
-50.0%
Q3 2019$46,034,000913,3420.00%
Other shareholders
10X GENOMICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 708,528$29,226,780100.00%
Meritech Capital Associates V L.L.C. 494,236$20,387,2356.48%
Sands Capital Ventures, LLC 481,770$19,873,0135.88%
Decheng Capital Management III (Cayman), LLC 359,554$14,831,6034.95%
Iron Triangle Partners LP 666,945$27,511,4814.02%
Endurant Capital Management LP 71,044$2,930,5652.63%
Brown Capital Management 3,081,105$127,095,5811.95%
RTW INVESTMENTS, LP 1,519,956$62,698,1851.32%
Parametrica Management Ltd 15,300$631,1251.06%
Capital Impact Advisors, LLC 14,821$611,3661.02%
View complete list of 10X GENOMICS INC shareholders